HomeAI · summaries
Storia in 2 fonti
Next-generation automated insulin delivery algorithm raises time in range in diabetes
NEW ORLEANS — A next-generation automated insulin delivery algorithm was tied to improved glycemic outcomes compared with a currently available system, according to data presented at the American Diabetes Association Scientific Sessions.In the STRIVE trial, researchers assessed glycemic outcomes, insulin delivery and device usage among people with type 1 or type 2 diabetes using the
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
Long-term glycemic outcomes similar for children using Control-IQ, Omnipod 5 systems
Children with type 1 diabetes had similar long-term glycemic outcomes with two different automated insulin delivery systems, researchers reported in a paper published in Diabetes…
- ·
Next-generation automated insulin delivery algorithm raises time in range in diabetes
NEW ORLEANS — A next-generation automated insulin delivery algorithm was tied to improved glycemic outcomes compared with a currently available system, according to data presented…
- ·
morningstar.com
Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort,…
Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care
- ·
Automated insulin delivery may fill ‘major gap’ in diabetes care during hospitalization
NEW ORLEANS —Use of automated insulin delivery during hospitalization may improve glycemic outcomes for adults with insulin-treated diabetes, according to data presented at the…
- ·
Automated insulin delivery system lowers HbA1c in patients with type 2 diabetes
NEW ORLEANS — In adults with insulin-treated type 2 diabetes, an automated insulin delivery system conferred lower HbA1c and improved time in range at 13 weeks, researchers…